Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study

scientific article published on 12 October 2019

Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00296-019-04451-0
P698PubMed publication ID31606775

P50authorVirginia Pascual-RamosQ88332816
Irazú Contreras-YáñezQ89702127
Guillermo Guaracha-BasáñezQ90673381
P2860cites workThe concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic reviewQ26864018
Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patientsQ30235042
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 updateQ30244903
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severityQ34238357
Clinical inertiaQ34428121
The recognition and assessment of cardiovascular risk in people with rheumatoid arthritis in primary care: a questionnaire-based study of general practitionersQ84207842
Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality IndicatorsQ88041807
Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin americaQ34495257
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatmentQ34563216
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studiesQ34889152
Translating patient education theory into practice: developing material to address the cardiovascular education needs of people with rheumatoid arthritis.Q35069789
Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS andQ35185494
Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective studyQ35617716
Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy mattersQ35842618
Redefining overweight and obesity in rheumatoid arthritis patients.Q36013923
Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritisQ36320021
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA studyQ36757060
Cardiovascular risk factor management in patients with RA compared to matched non-RA patientsQ36795979
Hypertension in rheumatoid arthritis.Q37158219
Challenges in the management of rheumatoid arthritis in developing countries.Q37265648
Hypoalphalipoproteinemia in populations of Native American ancestry: an opportunity to assess the interaction of genes and the environmentQ37413192
Improving doctor-patient communication: examining innovative modalities vis-a-vis effective patient-centric care management technologyQ37461293
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).Q37465556
Obesity paradox does existQ37577182
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectivesQ37812524
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.Q37883018
Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI.Q37890664
Cardiovascular risk management in rheumatoid arthritis: A large gap to closeQ38833212
Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid ArthritisQ39995428
Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritisQ40742537
Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritisQ40835686
Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience.Q41928172
Therapeutic inertia in the outpatient management of dyslipidemia in patients with ischemic heart disease. The inertia studyQ42781735
Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006.Q43002728
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?Q43255462
Are obese patients assisted in losing weight?Q44409621
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?Q45235877
Clinical inertia contributes to poor diabetes control in a primary care settingQ46354116
Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management.Q47988471
Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendationsQ48008568
Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiencesQ49849009
Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs.Q51129263
Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients.Q51211966
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.Q52684480
Selection bias and information bias in clinical research.Q53066944
Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritisQ59394301
Very early 'Rheumatoid' arthritis cohorts: limited by selectionQ79249639
Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammationQ80932706
P433issue3
P921main subjectrheumatoid arthritisQ187255
P304page(s)405-414
P577publication date2019-10-12
P1433published inRheumatology InternationalQ15763689
P1476titleCardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study
P478volume40

Search more.